CoLabs Intl. Corp marketed KLĒNSKIN WASH ON SUNSCREEN, an OTC sunscreen wash, without an FDA-approved application or authorized dosage form.
What happened
In May 2024, FDA reviewed the product labeling, including the website https://www.klenskin.com/, and found KLĒNSKIN WASH ON SUNSCREEN available for purchase without a prescription. The labeling claims broad-spectrum SPF 30 protection and everyday sunscreen use, so FDA treated it as an OTC sunscreen drug product. FDA found no approved application and no final order authorizing a shampoo or face/body wash sunscreen dosage form.
What FDA found
The product is a drug because its labeling says it prevents sun damage and affects the body.
FD&C Act section 201(g)(1)(B)/(C), 21 U.S.C. 321(g)(1)(B)/(C)The product is misbranded because it is a nonprescription drug subject to section 505G but does not meet that section’s marketing requirements and has no approved application.
FD&C Act sections 502(ee) and 301(a), 21 U.S.C. 352(ee) and 331(a)A sunscreen in wash or shampoo dosage form is not one of the dosage forms allowed under the OTC sunscreen order, and no FDA order authorizes it.
FD&C Act section 505G(m)(2), 21 U.S.C. 355h(m)(2)No FDA-approved application under section 505 is in effect for the product.
FD&C Act section 505, 21 U.S.C. 355
What FDA wants
FDA asks the company to notify it in writing within 15 working days of receipt of the specific steps taken to correct the violations, including explanations and related documentation; if correction cannot be completed in that time, the company must state why and when it will be completed.
Who should pay attention
- OTC sunscreen brands
- companies making or selling wash-off sunscreen dosage forms
- retailers and online marketplaces listing KLĒNSKIN products
This is a summary. Read the original letter on fda.gov.